181 related articles for article (PubMed ID: 34809604)
1. Correlation and agreement between superb micro-vascular imaging and contrast-enhanced ultrasound for assessing radiofrequency ablation treatment of thyroid nodules: a preliminary study.
Lan Y; Li N; Song Q; Zhang MB; Luo YK; Zhang Y
BMC Med Imaging; 2021 Nov; 21(1):175. PubMed ID: 34809604
[TBL] [Abstract][Full Text] [Related]
2. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.
Yan L; Luo Y; Xiao J; Lin L
Eur Radiol; 2021 May; 31(5):3226-3236. PubMed ID: 33128600
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of Ablated Volume Measurement Is Higher with Contrast-Enhanced Ultrasound than with B-Mode Ultrasound after Benign Thyroid Nodule Radiofrequency Ablation-A Preliminary Study.
Schiaffino S; Serpi F; Rossi D; Ferrara V; Buonomenna C; Alì M; Monfardini L; Sconfienza LM; Mauri G
J Clin Med; 2020 May; 9(5):. PubMed ID: 32429487
[TBL] [Abstract][Full Text] [Related]
4. Superb microvascular imaging compared with contrast-enhanced ultrasound to assess microvessels in thyroid nodules.
Yongfeng Z; Ping Z; Hong P; Wengang L; Yan Z
J Med Ultrason (2001); 2020 Apr; 47(2):287-297. PubMed ID: 32125575
[TBL] [Abstract][Full Text] [Related]
5. Superb Microvascular Imaging Compared with Contrast-Enhanced Ultrasound for Assessing Laser Ablation Treatment of Benign Thyroid Nodules.
Liu W; Zhou P; Zhao Y; Tian S; Wu X
Biomed Res Int; 2018; 2018():1025657. PubMed ID: 30671442
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study.
Yan L; Li X; Xiao J; Li Y; Zhu Y; He H; Luo Y
Int J Hyperthermia; 2022; 39(1):40-47. PubMed ID: 34936850
[TBL] [Abstract][Full Text] [Related]
7. Superb microvascular imaging (SMI) compared with conventional ultrasound for evaluating thyroid nodules.
Lu R; Meng Y; Zhang Y; Zhao W; Wang X; Jin M; Guo R
BMC Med Imaging; 2017 Dec; 17(1):65. PubMed ID: 29281991
[TBL] [Abstract][Full Text] [Related]
8. Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules.
Bernardi S; Cavallaro M; Colombin G; Giudici F; Zuolo G; Zdjelar A; Dobrinja C; De Manzini N; Zanconati F; Cova MA; Stacul F; Fabris B
Front Endocrinol (Lausanne); 2020; 11():582550. PubMed ID: 33597921
[TBL] [Abstract][Full Text] [Related]
9. Inter-observer reliability in ultrasound measurement of benign thyroid nodules in the follow-up of radiofrequency ablation: a retrospective study.
Yan L; Luo Y; Song Q; Li N; Xiao J; Zhang Y; Zhu Y
Int J Hyperthermia; 2020 Nov; 37(1):1336-1344. PubMed ID: 33251890
[TBL] [Abstract][Full Text] [Related]
10. A Novel Strategy for Single-Session Ultrasound-Guided Radiofrequency Ablation of Large Benign Thyroid Nodules: A Pilot Cohort Study.
Yao Z; Wu T; Zheng B; Tan L; Lian Y; Liu B; Ren J
Front Endocrinol (Lausanne); 2020; 11():560508. PubMed ID: 33117279
[No Abstract] [Full Text] [Related]
11. Three-dimensional ultrasound VOCAL combined with contrast-enhanced ultrasound: an alternative to contrast-enhanced magnetic resonance imaging for evaluating ablation of benign uterine lesions.
Zhang J; Lyu G; Qiu J; Qiu S; Li Z; Lin M; Xiao X; Tang L; He J; Li X; Li S
Int J Hyperthermia; 2022; 39(1):1360-1370. PubMed ID: 36266251
[TBL] [Abstract][Full Text] [Related]
12. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
13. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
[TBL] [Abstract][Full Text] [Related]
14. Roles of contrast-enhanced ultrasonography in identifying volume change of benign thyroid nodule and optical time of secondary radiofrequency ablation.
Jiao Z; Luo Y; Song Q; Yan L; Zhu Y; Xie F
BMC Med Imaging; 2020 Jul; 20(1):79. PubMed ID: 32664884
[TBL] [Abstract][Full Text] [Related]
15. A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound.
Zhu Y; Jiao Z; Zhu L; Xie F; Song Q; Yan L; Luo Y; Zhang M
Front Endocrinol (Lausanne); 2022; 13():904459. PubMed ID: 35774147
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.
Zhao CK; Xu HX; Lu F; Sun LP; He YP; Guo LH; Li XL; Bo XW; Yue WW
Clin Hemorheol Microcirc; 2017; 65(4):393-405. PubMed ID: 27983547
[TBL] [Abstract][Full Text] [Related]
17. Superb Micro-vascular Imaging (SMI): a Doppler ultrasound technique with potential to identify, classify, and follow up endoleaks in patients after Endovascular Aneurysm Repair (EVAR).
Gabriel M; Tomczak J; Snoch-Ziółkiewicz M; Dzieciuchowicz Ł; Strauss E; Pawlaczyk K; Wojtusik D; Oszkinis G
Abdom Radiol (NY); 2018 Dec; 43(12):3479-3486. PubMed ID: 29876784
[TBL] [Abstract][Full Text] [Related]
18. Role of Superb Micro-Vascular Imaging in the Preoperative Evaluation of Thyroid Nodules: Comparison With Power Doppler Flow Imaging.
Kong J; Li JC; Wang HY; Wang YH; Zhao RN; Zhang Y; Jin J
J Ultrasound Med; 2017 Jul; 36(7):1329-1337. PubMed ID: 28463412
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.
Nemec U; Nemec SF; Novotny C; Weber M; Czerny C; Krestan CR
Eur Radiol; 2012 Jun; 22(6):1357-65. PubMed ID: 22322310
[TBL] [Abstract][Full Text] [Related]
20. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
